116 related articles for article (PubMed ID: 9243517)
1. Influence of epidermal growth factor and gastrin on the cell proliferation of human meningiomas versus astrocytic tumors maintained as ex vivo tissue cultures.
Camby I; Nagy N; Rombaut K; Gras T; Duponchelle C; Pasteels JL; Brotchi J; Kiss R; Salmon I
Neuropeptides; 1997 Jun; 31(3):217-25. PubMed ID: 9243517
[TBL] [Abstract][Full Text] [Related]
2. Influence of gastrin on human astrocytic tumor cell proliferation.
Camby I; Salmon I; Danguy A; Pasteels JL; Brotchi J; Martinez J; Kiss R
J Natl Cancer Inst; 1996 May; 88(9):594-600. PubMed ID: 8609660
[TBL] [Abstract][Full Text] [Related]
3. Hormonal dependency of cerebral meningiomas. Part 2: In vitro effect of steroids, bromocriptine, and epidermal growth factor on growth of meningiomas.
Adams EF; Schrell UM; Fahlbusch R; Thierauf P
J Neurosurg; 1990 Nov; 73(5):750-5. PubMed ID: 2213165
[TBL] [Abstract][Full Text] [Related]
4. Characterization of gastrin-induced cytostatic effect on cell proliferation in experimental malignant gliomas.
Lefranc F; Sadeghi N; Metens T; Brotchi J; Salmon I; Kiss R
Neurosurgery; 2003 Apr; 52(4):881-90; discussion 890-1. PubMed ID: 12657185
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of somatostatin receptors by epidermal growth factor and gastrin in pancreatic cancer cells.
Vidal C; Rauly I; Zeggari M; Delesque N; Esteve JP; Saint-Laurent N; Vaysse N; Susini C
Mol Pharmacol; 1994 Jul; 46(1):97-104. PubMed ID: 8058063
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of in vitro meningioma proliferation after growth factor stimulation by calcium channel antagonists: Part II--Additional growth factors, growth factor receptor immunohistochemistry, and intracellular calcium measurements.
Jensen RL; Lee YS; Guijrati M; Origitano TC; Wurster RD; Reichman OH
Neurosurgery; 1995 Nov; 37(5):937-46; discussion 946-7. PubMed ID: 8559343
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with epidermal growth factor and gastrin induces neogenesis of human islet {beta}-cells from pancreatic duct cells and an increase in functional {beta}-cell mass.
Suarez-Pinzon WL; Lakey JR; Brand SJ; Rabinovitch A
J Clin Endocrinol Metab; 2005 Jun; 90(6):3401-9. PubMed ID: 15769977
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor--receptors on cultured human meningioma cells.
Westphal M; Herrmann HD
Acta Neurochir (Wien); 1986; 83(1-2):62-6. PubMed ID: 3492089
[TBL] [Abstract][Full Text] [Related]
9. The influence of L-triiodothyronine, L-thyroxine, estradiol-17beta, the luteinizing-hormone-releasing hormone, the epidermal growth factor and gastrin on cell proliferation in organ cultures of 35 benign and 13 malignant human thyroid tumors.
Nagy N; Camby I; Decaestecker C; Chaboteaux C; Gras T; Darro F; Rocmans P; Kiss R; Salmon I
J Cancer Res Clin Oncol; 1999; 125(6):361-8. PubMed ID: 10363569
[TBL] [Abstract][Full Text] [Related]
10. Presence of epidermal growth factor, platelet-derived growth factor, and their receptors in human myometrial tissue and smooth muscle cells: their action in smooth muscle cells in vitro.
Rossi MJ; Chegini N; Masterson BJ
Endocrinology; 1992 Mar; 130(3):1716-27. PubMed ID: 1311246
[TBL] [Abstract][Full Text] [Related]
11. Influence of gastrin, gastrin receptor blockers, epidermal growth factor, and difluoromethylornithine on the growth and the activity of ornithine decarboxylase of colonic carcinoma cells.
Eggstein S; Imdahl A; Kohler M; Waibel M; Farthmann EH
J Cancer Res Clin Oncol; 1991; 117(1):37-42. PubMed ID: 1997467
[TBL] [Abstract][Full Text] [Related]
12. Gastrin induces heparin-binding epidermal growth factor-like growth factor in rat gastric epithelial cells transfected with gastrin receptor.
Miyazaki Y; Shinomura Y; Tsutsui S; Zushi S; Higashimoto Y; Kanayama S; Higashiyama S; Taniguchi N; Matsuzawa Y
Gastroenterology; 1999 Jan; 116(1):78-89. PubMed ID: 9869605
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of proliferation of human cerebral meningioma cells by suramin: effects on cell growth, cell cycle phases, extracellular growth factors, and PDGF-BB autocrine growth loop.
Schrell UM; Gauer S; Kiesewetter F; Bickel A; Hren J; Adams EF; Fahlbusch R
J Neurosurg; 1995 Apr; 82(4):600-7. PubMed ID: 7897522
[TBL] [Abstract][Full Text] [Related]
14. Divergent responses to epidermal growth factor in hormone sensitive and insensitive human prostate cancer cell lines.
MacDonald A; Habib FK
Br J Cancer; 1992 Feb; 65(2):177-82. PubMed ID: 1739613
[TBL] [Abstract][Full Text] [Related]
15. The influence of gastrin and/or cholecystokinin antagonists on the proliferation of three human astrocytic tumor cell lines.
Camby I; Salmon I; Oiry C; Galleyrand JC; Nagy N; Danguy A; Brotchi J; Pasteels JL; Martinez J; Kiss R
Neuropeptides; 1996 Oct; 30(5):433-7. PubMed ID: 8923504
[TBL] [Abstract][Full Text] [Related]
16. Meningiomas, epidermal growth factor and progesterone.
Koper JW; Lamberts SW
Hum Reprod; 1994 Jun; 9 Suppl 1():190-4. PubMed ID: 7962464
[TBL] [Abstract][Full Text] [Related]
17. The epidermal growth factor receptor is associated with phospholipase C-gamma 1 in meningiomas.
Johnson MD; Horiba M; Winnier AR; Arteaga CL
Hum Pathol; 1994 Feb; 25(2):146-53. PubMed ID: 8119714
[TBL] [Abstract][Full Text] [Related]
18. Characterization of insulin-like growth factor I and epidermal growth factor receptors in meningioma.
Kurihara M; Tokunaga Y; Tsutsumi K; Kawaguchi T; Shigematsu K; Niwa M; Mori K
J Neurosurg; 1989 Oct; 71(4):538-44. PubMed ID: 2552046
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the influence of anti-hormone and/or anti-growth factor neutralizing antibodies on cell clone architecture and the growth of human neoplastic astrocytic cell lines.
Camby I; Salmon I; Rorive S; Gras T; Darro F; Kruczynski A; Danguy A; Pasteels JL; Kiss R
J Neurooncol; 1994; 20(1):67-80. PubMed ID: 7807186
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of the gastrin receptor antagonist CR2093 on basal, gastrin-stimulated and growth factor-stimulated growth of the rat pancreatic cell line AR42J.
Watson SA; Clifford TL; Steele RJ
Anticancer Drugs; 1994 Oct; 5(5):591-7. PubMed ID: 7858292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
